Edgewell Personal Care CO 8-K filings
Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.
NYSE
Edgewell Personal Care reported Q3 FY26 results with organic net sales increasing 1.1% and adjusted EPS/EBITDA exceeding expectations, though the full-year outlook was narrowed.
NYSE
Edgewell Personal Care Company has announced a change in its Chief Supply Chain Officer role, with Paul R. Hibbert departing and Anthony Freve appointed to the position.
NYSE
Edgewell Personal Care announced second quarter fiscal 2026 results, with net sales and adjusted EPS exceeding expectations, while reaffirming full-year financial outlook.
NYSE
Edgewell Personal Care reported first quarter fiscal 2026 results ahead of expectations, successfully completed its Feminine Care divestiture, and reaffirmed its full-year outlook for continuing operations.
NYSE
Edgewell Personal Care Company has completed the sale of its Feminine Care business to Essity for $340 million, aiming to strengthen its balance sheet and focus on core brands.
NYSE
Edgewell Personal Care announced its fourth quarter and fiscal year 2025 results, revealing mixed performance with a net sales decrease for the full year but organic growth in Q4, alongside the strategic divestiture of its Feminine Care business and a new share repurchase authorization.
NYSE
Edgewell Personal Care Company announced a definitive agreement to sell its Feminine Care business, including Playtex, Stayfree, Carefree, and o.b. brands, to Essity for $340 million in cash.
NYSE
Edgewell Personal Care Company announced the departure of COO Daniel Sullivan and a new leadership structure to streamline operations and enhance efficiency.
NYSE
Edgewell Personal Care reported a challenging third fiscal quarter with net sales and EPS falling below expectations, leading to a revised downward full-year financial outlook.
NYSE
8-K: Edgewell Personal Care Announces Mixed Second Quarter Fiscal 2025 Results; Updates Full Year Outlook
Edgewell Personal Care reports a decrease in net sales and adjusted EPS for Q2 2025, while updating its full-year outlook to reflect a challenging economic environment.
NYSE
Edgewell Personal Care reports a decrease in net sales and EPS for Q1 2025, impacted by unfavorable currency movements, while maintaining its full-year outlook.
NYSE
Edgewell Personal Care Company has amended its previous 8-K filing to disclose the compensation arrangements for its newly appointed Chief Operating Officer, Daniel J. Sullivan, and Chief Financial Officer, Francesca Weissman.
NYSE
Edgewell Personal Care's fiscal year 2024 saw a slight increase in net sales but a decrease in GAAP EPS, while the company anticipates growth in organic net sales and adjusted EPS for fiscal year 2025.
NYSE
Edgewell Personal Care Company has appointed Stephanie Stahl to its Board of Directors, increasing the board size to 11 members.
NYSE
Edgewell Personal Care has announced key executive leadership changes, including a new COO and CFO, alongside a streamlined organizational structure to drive growth.
NYSE
8-K: Edgewell Personal Care Reports Mixed Q3 Results, Raises Full-Year Adjusted EPS and EBITDA Outlook
Edgewell Personal Care's third quarter saw a slight decrease in net sales but significant gross margin expansion, leading to an increase in adjusted earnings per share and an updated full-year outlook.
NYSE
Edgewell Personal Care saw a slight increase in net sales but a significant jump in earnings per share, leading to an updated full-year outlook.
NYSE
Edgewell Personal Care Company has entered into a Restatement Agreement, amending and restating its existing credit agreement and securing a $425 million revolving facility.
NYSE
Edgewell Personal Care has announced the appointment of John Dunham as its new Chief Accounting Officer, effective March 18, 2024.
NYSE
Edgewell Personal Care saw a 4.2% increase in net sales in the first quarter of fiscal year 2024, driven by international growth, but experienced a decline in earnings per share.